PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-05-21

Date Title Company
21-May-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
21-May-2020 Abbott Releases Interim Clinical Study Data on ID NOW COVID-19 Rapid Test Showing Strong Agreement to Lab-Based Molecular PCR Tests Abbott
21-May-2020 Akebia Therapeutics Announces Change to Virtual Annual Meeting of Stockholders Akebia Therapeutics
21-May-2020 Correvio Obtains Final Order for Plan of Arrangement Correvio Pharma Corp
21-May-2020 Hoth Announces Proposed Public Offering of Common Stock Hoth Therapeutics, Inc.
21-May-2020 PathSpot Raises $6.5 Million in Series A Financing PathSpot
21-May-2020 NORD Supports Rare Disease Nonprofits Impacted by COVID-19 with New Rapid Response Leadership Series National Organization for Rare Disorders (NORD)
21-May-2020 Las Vegas-Based Biopharmaceutical Company EUCYT Promotes Translational Cell Scientist Expert to Chief Scientific Officer Newswire
21-May-2020 European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat Astellas Pharma Inc
21-May-2020 Just Add Water: Oxitec’s New Friendly Mosquito Mini-Capsule Technology Rapidly Suppresses 95% of Disease-Spreading Aedes aegypti in Brazil Trial Oxitec Ltd
21-May-2020 Mental health app Flow joins ORCHA App Library ORCHA
21-May-2020 Clinical trials company calls for unity and action to address lack of patient diversity in research Innovative Trials
21-May-2020 Santhera Completes Enrollment of Phase 3 SIDEROS Study with Puldysa® (Idebenone) in Duchenne Muscular Dystrophy (DMD) Santhera Pharmaceuticals
21-May-2020 Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer AstraZeneca
21-May-2020 Approval of olaparib offers men first gene-targeted medicine for prostate cancer The Institute of Cancer Research
21-May-2020 European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat Astellas Pharma Inc
21-May-2020 Yemen: In Aden’s only COVID-19 treatment centre we are seeing a catastrophe unfold Doctors Without Borders
21-May-2020 FlowMetric Diagnostics, Inc. Announces the Expansion of Their Core Services to Include Serological Antibody Testing for SARS-CoV-2 Exposure FlowMetric, Inc.
21-May-2020 INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models INOVIO
21-May-2020 Gilead and Galapagos Announce Positive Topline Results of Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis Gilead